Vivek Kumar, SBI Cap Securities advice traders to buy Ranbaxy Labs for target of Rs 620-630.
first published: Nov 8, 2012 06:43 pm
A collection of the most-viewed Moneycontrol videos.

US-Israel Strike Wipes Out Iran’s Top Leadership Including Khamenei | Khamenei News

U.S.-Iran Conflict Will Have Huge Impact On Global Markets, Businesses, Supply Chain: Nalin Mehta

Rising Bharat Summit 2026 | “Satellite Can Go Where Others Can’t” – Jyotiraditya Scindia

Rising Bharat Summit 2026 | “AI Creates More Opportunities” – Jyotiraditya Scindia
You are already a Moneycontrol Pro user.


